157 related articles for article (PubMed ID: 28187492)
21. Warfarin and pharmacogenomic testing: what would Pascal do?
Teagarden JR
Pharmacotherapy; 2009 Mar; 29(3):245-7. PubMed ID: 19249943
[No Abstract] [Full Text] [Related]
22. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenomic testing for warfarin dosing: we are ready now.
Wu AH
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1483-5. PubMed ID: 19954308
[No Abstract] [Full Text] [Related]
24. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
[TBL] [Abstract][Full Text] [Related]
25. Prediction of warfarin dose: why, when and how?
Eriksson N; Wadelius M
Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
[TBL] [Abstract][Full Text] [Related]
26. Genetic testing for warfarin therapy initiation.
Hynicka LM; Cahoon WD; Bukaveckas BL
Ann Pharmacother; 2008 Sep; 42(9):1298-303. PubMed ID: 18682545
[TBL] [Abstract][Full Text] [Related]
27. Individual genomes instead of race for personalized medicine.
Ng PC; Zhao Q; Levy S; Strausberg RL; Venter JC
Clin Pharmacol Ther; 2008 Sep; 84(3):306-9. PubMed ID: 18714319
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics: The right drug for you.
Drew L
Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
[No Abstract] [Full Text] [Related]
29. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
[TBL] [Abstract][Full Text] [Related]
30. Genetic influences on the response to warfarin.
Kamali F
Curr Opin Hematol; 2006 Sep; 13(5):357-61. PubMed ID: 16888441
[TBL] [Abstract][Full Text] [Related]
31. Precision dosing of warfarin: open questions and strategies.
Li X; Li D; Wu JC; Liu ZQ; Zhou HH; Yin JY
Pharmacogenomics J; 2019 Jun; 19(3):219-229. PubMed ID: 30745565
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
Cavallari LH; Mason DL
Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of warfarin.
Kamali F; Wynne H
Annu Rev Med; 2010; 61():63-75. PubMed ID: 19686083
[TBL] [Abstract][Full Text] [Related]
34. Monitoring may need to be prolonged in patients given warfarin and amiodarone.
Tomlinson B; Young RP; Chan TY; Critchley JA; Chan JC
BMJ; 1996 Aug; 313(7052):301-2. PubMed ID: 8704564
[No Abstract] [Full Text] [Related]
35. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
Schwartz JB; Kane L; Moore K; Wu AH
J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of pharmacogenetic-guided warfarin dosing in Thailand.
Chong HY; Saokaew S; Dumrongprat K; Permsuwan U; Wu DB; Sritara P; Chaiyakunapruk N
Thromb Res; 2014 Dec; 134(6):1278-84. PubMed ID: 25456732
[TBL] [Abstract][Full Text] [Related]
37. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
[TBL] [Abstract][Full Text] [Related]
38. Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines.
Bush WS; Cooke Bailey JN; Beno MF; Crawford DC
Public Health Genomics; 2019; 22(1-2):16-24. PubMed ID: 31454805
[TBL] [Abstract][Full Text] [Related]
39. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
[No Abstract] [Full Text] [Related]
40. Precision Medicine Versus Evidence-Based Medicine: Individual Treatment Effect Versus Average Treatment Effect.
Blackstone EH
Circulation; 2019 Oct; 140(15):1236-1238. PubMed ID: 31589490
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
